American Academy of Child Adolescent Psychiatry.   Report issue

Foundation Phase 2 Phase 4
Founded: Washington D.C. United States (1953)

Organization Overview

First Clinical Trial
2005
NCT00399763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

ketamine (ketalar) (1 trial)

midazolam (versed) (1 trial)

Drugs in Phase 2 Trials (1)

acetylcysteine (mucomyst) (2 trials)

Drugs in Other Trials (1)

atomoxetine (strattera) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Disease (Phase 4)

Marijuana Abuse (Phase 2)

Syndrome (Phase 2)

Tourette Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4